請用此 Handle URI 來引用此文件:
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/43402
完整後設資料紀錄
DC 欄位 | 值 | 語言 |
---|---|---|
dc.contributor.advisor | 余宏政(Hong-Jeng Yu),鄭劍廷(Chiang-Ting Chien) | |
dc.contributor.author | Wei-Chia Lee | en |
dc.contributor.author | 李偉嘉 | zh_TW |
dc.date.accessioned | 2021-06-15T01:54:33Z | - |
dc.date.available | 2011-09-15 | |
dc.date.copyright | 2009-09-15 | |
dc.date.issued | 2009 | |
dc.date.submitted | 2009-06-30 | |
dc.identifier.citation | Abrams P, Cardozo L, Fall M, Griffiths D, Rosier P, Ulmsten U, Van Kerrebroeck P, Victor A, Wein A: The standardisation of terminology in lower urinary tract function: report from the standardisation sub-committee of the International Continence Society. Urology. 2003; 61: 37-49.
Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1. Diagnosis and classification of diabetes mellitus, provisional report of a WHO consultation. Diabet Med 1998; 15:539-553. Alberti KG, Zimmet P, Shaw J; IDF Epidemiology Task Force Consensus Group. The metabolic syndrome- A new worldwide definition. Lancet 2005; 366: 1059-1062. American Diabetes Association: Standards of medical care in diabetes-2008. Diabetes Care 2008; 31(suppl 1) : S12-S54. Andersson KE and Arner A.: Urinary bladder contraction and relaxation: physiology and pathophysiology. Physiol Rev. 2004: 84; 935-986. Andersson KE: Antimuscarinics for treatment of overactive bladder. Lancet Neurol 2004; 3: 46-53 Apfeld J, O'Connor G, McDonagh T, DiStefano PS and Curtis R: The AMP-activated protein kinase AAK-2 links energy levels and insulin-like signals to lifespan in C. elegans. Genes Dev. 2004; 18: 3004-3009. Balasubramanian T: Role for the urinary bladder in pathogenesis of metabolic syndrome in Wistar rats. Singapore Med J 2008; 49: 644-649. Baur JA, Pearson KJ, Price NL, Jamieson HA, Lerin C, Kalra A, et al: Resveratrol improves health and survival of mice on a high-calorie diet. Nature. 2006; 444: 337-342. Behr-Roussel D, Oudot A, Caisey S, Coz OL, Gorny D, Bernabé J, Wayman C, Alexandre L, Giuliano FA.Daily treatment with sildenafil reverses endothelial dysfunction and oxidative stress in an animal model of insulin resistance Eur Urol. 2008, 53:1272-1280. Berger AP, Deibl M, Halpern EJ, Lechleitner M, Bektic J, Horninger W, Fritsche G, Steiner H, Pelzer A, Bartsch G: Vascular damage induced by type 2 diabetes mellitus as a risk factor for benign prostatic hyperplasia. Diabetologia. 2005; 48: 784-789. Beshay E and Carrier S: Oxidative stress plays a role in diabetes-induced bladder dysfunction in a rat model. Urology. 2004; 64: 1062-1067. Bloomgarden ZT. The 1stWorld Congress on the Insulin Resistance Syndrome. Diabetes Care. 2004; 27:602-609. Borst SE. The role of TNF-alpha in insulin resistance. Endocrine. 2004, 23: 177-182. Bray GA, Nielsen SJ, Popkin BM: Consumption of high-fructose corn syrup in beverages may play a role in the epidemic of obesity. Am J Clin Nutr 2004; 79: 537-543. Brown JS, Wessells H, Chancellor MB, Howards SS, Stamm WE, Stapleton AE, Steers WD, Van Den Eeden SK, McVary KT: Urologic complications of diabetes. Diabetes Care. 2005; 28: 177-185. Brown JS, Vittinghoff E, Lin F, Nyberg LM, Kusek JW, Kanaya AM: Prevalence and risk factors for urinary incontinence in women with type 2 diabetes and impaired fasting glucose: findings from the National Health and Nutrition Examination Survey (NHANES) 2001-2002. Diabetes Care 2006; 29: 1307-1312. Cameron AJ, Shaw JE, Zimmet PZ. The metabolic syndrome: Prevalence in worldwide populations. Endocrinol Metab Clin North Am 2004; 33: 351-375. Changolkar AK, Hypolite JA, Disanto M, Oates PJ, Wein AJ and Chacko S: Diabetes induced decrease in detrusor smooth muscle force is associated with oxidative stress and overactivity of aldose reductase. J Urol. 2005; 173: 309-313. Chen WP, Chi TC, Chuang LM, Su MJ. Resveratrol enhances insulin secretion by blocking K(ATP) and K(V) channels of beta cells. Eur J Pharmacol 2007; 568: 269-277. Cheng JT, Yu BC, Tong YC: Changes of M3-muscarinic receptor protein and mRNA expressions in the bladder urothelium and muscle layer of streptozotocin-induced diabetic rats. Neurosci Lett. 2007; 423: 1-5. Cheng JT and Tong YC: Alterations of nerve-growth factor and p75NTR expressions in urinary bladder of fructose-fed obese rats. Neurosci Lett. 2008; 441: 25-28. Chien CT, Yu HJ, Lin TB and Chen CF: Neural mechanisms of impaired micturition reflex in rats with acute partial bladder outlet obstruction. Neuroscience 2000; 96: 221-230. Chokkalingam AP, Gao YT, Deng J, Stanczyk FZ, Sesterhenn IA, Mostofi FK, Fraumeni JF Jr, Hsing AW. Insulin-like growth factors and risk of benign prostatic hyperplasia. Prostate 2002; 52: 98-105. Cockayne DA, Hamilton SG, Zhu QM, Dunn PM, Zhong Y, Novakovic S, Malmberg AB, Cain G, Berson A, Kassotakis L: Urinary bladder hyporeflexia and reduced pain-related behaviour in P2X3-deficient mice. Nature. 2000; 407: 1011-1015. Danforth KN, Townsend MK, Curhan GC, Resnick NM, Grodstein F. Type 2 diabetes mellitus and risk of stress, urge and mixed urinary incontinence. J Urol. 2009; 181:193-197. Deji N, Kume S, Araki S, Soumura M, Sugimoto T, Isshiki K, Chin-Kanasaki M, Sakaguchi M, Koya D, Haneda M, Kashiwagi A, Uzu T. Structural and functional changes in the kidneys of high-fat diet-induced obese mice. Am J Physiol Renal Physiol. 2009;296: F118-26. Donath MY, Schumann DM, Faulenbach M, Ellingsgaard H, Perren A, Ehses JA. Islet inflammation in type 2 diabetes: from metabolic stress to therapy. Diabetes Care. 2008, 31; (Suppl 2):S161-164. El-Atat FA, Stas SN, McFarlane SI, Sowers JR: The relationship between hyperinsulinemia, hypertension and progressive renal disease. J Am Soc Nephrol. 2004; 15: 2816-2827. Ellenberg M: Development of urinary bladder dysfunction in diabetes mellitus. Ann Intern Med. 1980; 92: 321-323. Esposito K, Giugliano F, Martedi E, Feola G, Marfella R, D'Armiento M, Giugliano D.: High proportions of erectile dysfunction in men with the metabolic syndrome. Diabetes Care. 2005, 28: 1201-1203. Esteghamati A, Rashidi A, Nikfallah A and Youse- fizadeh A: The association between urodynamic findings and microvascular complications in patients with long-term type 2 diabetes but without voiding symptoms. Diabetes Res Clin Pract 2007; 78: 42-50. Fonseca V and Jawa A: Endothelial and erectile dysfunction, diabetes mellitus, and the metabolic syndrome: common pathways and treatments? Am J Cardiol. 2005, 96: 13M-18M. Ford ES, Giles WH, Dietz WH: Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA. 2002; 287: 356-359. Fujii H, Yokozawa T, Kim YA, Tohda C, Nonaka G. Protective effect of grape seed polyphenols against high glucose-induced oxidative stress. Biosci Biotechnol Biochem 2006; 70:2104-2111. Geerlings SE, Stolk RP, Camps MJ, Netten PM, Hoekstra JB, Bouter KP, Bravenboer B, Collet JT, Jansz AR, Hoepelman AI. Asymptomatic bacteriuria may be considered a complication in women with diabetes. Diabetes Mellitus Women Asymptomatic Bacteriuria Utrecht Study Group. Diabetes Care. 2000;23:744-749 Gonzalez-Gay MA, De Matias JM, Gonzalez-Juanatey C, Garcia-Porrua C, Sanchez-Andrade A, Martin J, Llorca J. Anti-tumor necrosis factor-α blockade improves insulin resistance in patients with rheumatoid arthritis. Clin. Exp. Rheumatol. 2006; 24: 83–86. Gray MA, Wang CC, Sacks MS, Yoshimura N, Chancellor M, Nagatomi J: Time-dependent alterations of select genes in streptozotocin-induced diabetic rat bladder. Urology 2008; 71: 1214-9. Grundy SM, Brewer HB Jr, Cleeman JI, Smith SC Jr, Lenfant C; American Heart Association; National Heart, Lung, and Blood Institute. Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation 2004: 109: 433-438 Hammarsten J, Högstedt B, Holthuis N, Mellström D: Components of the metabolic syndrome-risk factors for the development of benign prostatic hyperplasia. Prostate cancer Prostatic Dis. 1998; 1: 157-162. Hamdy O, Ledbury S, Mullooly C, Jarema C, Porter S, Ovalle K, Moussa A, Caselli A, Caballero AE, Economides PA, Veves A, Horton ES: Lifestyle modification improves endothelial function in obese subjects with the insulin resistance syndrome. Diabetes Care. 2003; 26: 2119-2125. Hegde SS, Mandel DA, Wilford MR, Briaud S, Ford AP, Eglen RM: Evidence for purinergic neurotransmission in the urinary bladder of pithed rats. Eur J Pharmacol 1998; 349: 75-82 Hill SR, Fayyad AM, Jones GR: Diabetes mellitus and femal lower urinary tract symptoms: A review. Neurourol Urodyn. 2008, 27: 362-367. Hotamisligil GS, Shargill NS, Spiegelman BM: Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science 1993; 259, 87–91. Hotamisligil GS, Arner P, Caro JF, Atkinson RL, Spiegelman BM: Increased adipose tissue expression of tumor necrosis factor-α in human obesity and insulin resistance. J. Clin. Invest. 1995; 95:2409–2415. Hwang LC, Bai CH, Chen CJ: Prevalence of obesity and metabolic syndrome in Taiwan. J Formos Med Assoc 2006: 105; 626-635. Ishigooka M, Hashimoto T, Hayami S, Suzuki Y, Ichiyanagi O and Nakada T: Thermoreceptor mediated bladder sensation in patients with diabetic cystopathy. Int Urol Nephrol. 1997; 29: 551-555. Janig W, Morrison: Functional properties of spinal visceral afferents supplying abdominal and pelvic organs, with special emphasis on visceral nociception. Prog Brain Res. 1986;67:87-114 Kahn R, Buse J, Ferrannini E, Stern M. The Metabolic Syndrome: Time for a Critical Appraisal: Joint statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes care 2005, 28:2289-2304. Kaplan SA, Te AE, Blaivas JG: Urodynamic findings in patients with diabetic cystopathy. J Urol. 1995; 153: 342-344. Lawrence JM, Lukacz ES, Liu IL, Nager CW, Luber KM. Pelvic floor disorders, diabetes, and obesity in women: findings from the Kaiser Permanente Continence Associated Risk Epidemiology Study. Diabetes Care 2007; 30: 2536-41. Le KA and Tappy L: Metabolic effects of fructose. Curr Opin Clin Nutr Metab Care 2006; 9: 469-475. Lee WC, Wu HP, Tai TY, Liu SP, Chen J, Yu HJ: Effects of diabetes on female voiding behavior. J Urol. 2004; 172: 989-992. Lee WC, Wu CC, Wu HP, Tai TY. Lower urinary tract symptoms and uroflowmetry in women with type 2 diabetes mellitus with and without bladder dysfunction. Urology 2007; 69: 685-90. Lee WC, Chien CT, Yu HJ, Lee SW. Bladder dysfunction in rats with metabolic syndrome induced by long-term fructose feeding. J Urol 2008; 179: 2470-6. Lee WC, Wu HP, Tai TY, Yu HJ, Chiang PH. Investigation of urodynamic characteristics and bladder sensory function in the early stages of diabetic bladder dysfunction in women with type 2 diabetes. J Urol 2009; 181: 198-203. Liu G and Daneshgari F: Alterations in neurogenically mediated contractile responses of urinary bladder in rats with diabetes. Am J Physiol Renal Physiol. 2005; 288: F1220-1226. Liu G, Lin YH, Yamada Y and Daneshgari F: External urethral sphincter activity in diabetic rats. Neurourol Urodyn. 2008; 27: 429-434. Liu HT, Kuo HC. Urinary nerve growth factor level could be a potential biomarker for diagnosis of overactive bladder. J Urol. 2008; 179: 2270-2274. Longhurst PA and Uvelius B: Pharmacological techniques for the in vitro study of the urinary bladder. J Pharmacol Toxicol Methods 2001; 45: 91-108. Maiorana A, O'Driscoll G, Taylor R, Green D: Exercise and the nitric oxide vasodilator system. Sports Med. 2003; 33: 1013-1035. Masson EA, Veves A, Fernando D, Boulton AJ. Current perception thresholds: a new, quick, and reproducible method for the assessment of peripheral neuropathy in diabetes mellitus. Diabetologia 1989; 32: 724-728. Mastri AR. Neuropathology of diabetic neurogenic bladder. Ann Intern Med. 1980; 92: 316-318. Masuda H: Significance of nitric oxide and its modulation mechanisms by endogenous nitric oxide synthase inhibitors and arginase in the micturition disorders and erectile dysfunction. Int J Urol. 2008; 15: 128-34 McVary KT, Siegel RL, Carlsson M. Sildenafil citrate improves erectile function and lower urinary tract symptoms independent of baseline body mass index or LUTS severity. Urology. 2008; 72:575-579 Michel MC, Mehlburger L, Schumacher H, Bressel HU, Goepel M: Effect of diabetes on lower urinary tract symptoms in patients with benign prostatic hyperplasia. J Urol. 2000; 163: 1725-1729. Must A, Spadano J, Coakley EH, Field AE, Colditz G, Dietz WH. The disease burden associated with overweight and obesity. JAMA. 1999, 282:1523-1529. Nandeesha H, Koner BC, Dorairajan LN, Sen SK: Hyperinsulinemia and dyslipidemia in non-diabetic benign prostatic hyperplasia. Clin Chim Acta. 2006; 370: 89-93. Nobe K, Yamazaki T, Tsumita N, Hashimoto T, Honda K.: Glucose-dependent enhancement of diabetic bladder contraction is associated with a rho kinase-regulated protein kinase C pathway. J Pharmacol Exp Ther. 2009; 328:940-950. Ouslander JG: Management of overactive bladder. N Engl J Med 2004; 350: 786-799. Pinna C, Zanardo R, Puglisi L: Prostaglandin-release impairment in the bladder epithelium of streptozotocin-induced diabetic rats. Eur J Pharmacol. 2000; 388: 267-273. Rachon D, Rimoldi G, Wuttke W. In vitro effects of genistein and resveratrol on the production of interferon-gamma (IFNgamma) and interleukin-10 (IL-10) by stimulated murine splenocytes. Phytomedicine 2006; 13:419-424. Rapidi CA, Karandreas N, Katsifotis C, Benroubi M, Petropoulou K, Theodorou C: A combined urodynamic and electrophysiological study of diabetic cystopathy. Neurourol Urodyn. 2006; 25: 32-38. Reaven GM: Banting Lecture 1988. Role of insulin resistance in human disease. Diabetes 1988; 37: 1595-1607. Rizk DE, Padmanabhan RK, Tariq S, Shafiullah M, Ahmed I: Ultra-structural morphological abnormalities of the urinary bladder in streptozotocin-induced diabetic female rats. Int Urogynecol J Pelvic Floor Dysfunct. 2006; 17: 143-154. Rohrmann S, Smit E, Giovannucci E, Platz EA: Association between markers of the metabolic syndrome and lower urinary tract symptoms in the Third National Health and Nutrition Examination Survey (NHANES III). Int J Obes (Lond). 2005, 29: 310-316. Rosen RC: Update on the relationship between sexual dysfunction and lower urinary tract symptoms/benign prostatic hyperplasia. Curr Opin Urol. 2006;16:11-19. Sarma AV, Burke JP, Jacobson DJ, McGree ME, St Sauver J, Girman CJ, Lieber MM, Herman W, Macoska J, Montie JE: Associations between diabetes and clinical markers of benign prostatic hyperplasia among community-dwelling Black and White men. Diabetes Care. 2008; 31: 476-482. Sasaki K, Chancellor MB, Phelan MW, Yokoyama T, Fraser MO, Seki S, Kubo K, Kumon H, Groat WC, Yoshimura N: Diabetic cystopathy correlates with a long-term decrease in nerve growth factor levels in the bladder and lumbosacral dorsal root Ganglia. J Urol. 2002; 168: 1259-1264. Sasaki K, Yoshimura N, Chancellor MB: Implications of diabetes mellitus in urology. Urol Clin North Am 2003; 30:1-12. Sasaki K, Chancellor MB, Goins WF, Phelan MW, Glorioso JC, de Groat WC, Yoshimura N: Gene therapy using replication-defective herpes simplex virus vectors expressing nerve growth factor in a rat model of diabetic cystopathy. Diabetes 2004; 53: 2723-2730. Sharma S, Anjaneyulu M, Kulkarni SK, Chopra K. Resveratrol, a polyphenolic phytoalexin, attenuates diabetic nephropathy in rats. Pharmacology 2006; 76:69-75. Srilatha B, Adaikan PG. Characterization of hypertriglyceridemia-induced erectile dysfunction. Urology. 2006;67:642-646. Subak LL, Wing R, West DS, Franklin F, Vittinghoff E, Creasman JM, Richter HE, Myers D, Burgio KL, Gorin AA, Macer J, Kusek JW, Grady D; PRIDE Investigators: Weight loss to treat urinary incontinence in overweight and obese women. N Engl J Med. 2009; 360: 481-490. Temml C, Obermayr R, Marszalek M, Rauchenwald M, Madersbacher S, Ponholzer A. Are lower urinary tract symptoms influenced by metabolic syndrome? Urology. 2009; 73:544-548. Tong YC, Chin WT, Cheng JT: Alterations in urinary bladder M2-muscarinic receptor protein and mRNA in 2-week streptozotocin-induced diabetic rats. Neurosci Lett 1999; 277: 173–176. Tong YC, Cheng JT, Wan WC. Effects of Ba-Wei-Die-Huang-Wan on the cholinergic function and protein expression of M2 muscarinic receptor of the urinary bladder in diabetic rats. Neurosci Lett. 2002, 330:21-24. Tong YC, Cheng JT, Hsu CT: Alterations of M(2)-muscarinic receptor protein and mRNA expression in the urothelium and muscle layer of the streptozotocin-induced diabetic rat urinary bladder. Neurosci Lett. 2006; 406: 216-221. a Tong, YC, Cheng, JT: Alterations of M2,3-muscarinic receptor protein and mRNA expression in the bladder of the fructose fed obese rat. J Urol, 2007; 178: 1537-1542. b Tong, YC, Cheng, JT: Aldose reductase inhibitor ONO-2235 restores the alterations of bladder nerve growth factor and neurotrophin receptor p75 genetic expression in streptozotocin induced diabetic rats. J Urol. 2007;178:2203-2207. Torimoto K, Fraser MO, Hirao Y, De Groat WC, Chancellor MB and Yoshimura N: Urethral dysfunction in diabetic rats. J Urol. 2004; 171: 1959-1964. Torimoto K, Hirao Y, Matsuyoshi H, de Groat WC, Chancellor MB, Yoshimura N: alpha1-Adrenergic mechanism in diabetic urethral dysfunction in rats. J Urol. 2005; 173: 1027-1032. Ueda T, Yoshimura N and Yoshida O: Diabetic cystopathy: relationship to autonomic neuropathy detected by sympathetic skin response. J Urol. 1997; 157: 580-584. Ukimura O,Ushijima S, Honjo H,Iwata T, Suzuki K, Hirahara N, Okihara K, Mizutani Y, Kawauchi A, Miki T: Neuroselective current perception threshold evaluation of bladder mucosal sensory function. Eur Urol 2004; 45:70-76. Van Poppel H, Stessens R, Van Damme B, Carton H, Baert L: Diabetic cystopathy: Neuropathological examination of urinary bladder biopsies. Eur Urol. 1988; 15: 128-131. Vasudevan H, Xiang H, McNeill JH: Differential regulation of insulin resistance and hypertension by sex hormones in fructose-fed male rats. Am J Physiol Heart Circ Physiol 2005; 289: H1335-1342. Wachter SD and Wyndaele JJ: Can the sensory threshold toward electrical stimulation be used to quantify the subjective perception of bladder filling? A study in young healthy volunteers. Urology 2001; 57: 655–659. Wang CC, Nagatomi J, Toosi KK, Yoshimura N, Hsieh JH, Chancellor MB, Sacks MS: Diabetes-induced alterations in biomechanical properties of urinary bladder wall in rats. Urology 2009, 73: 911-91. Woo KS, Chook P, Yu CW, Sung RY, Qiao M, Leung SS, Lam CW, Metreweli C, Celermajer DS: Effects of diet and exercise on obesity-related vascular dysfunction in children. Circulation. 2004; 109: 1981-1986. Wyne KL. Free fatty acids and type 2 diabetes mellitus: Am J Med. 2003, 115 (Suppl 8A):29S-36S. Yamaguchi C, Sakakibara R, Uchiyama T, Yamamoto T, Ito T, Liu Z, Awa Y, Yamamoto K, Nomura F, Yamanishi T: Overactive bladder in diabetes: a peripheral or central mechanism? Neurourol Urodyn. 2007; 26: 807-813. Yang Z, Dolber PC, Fraser MO: Diabetic urethropathy compounds the effects of diabetic cystopathy. J Urol. 2007; 178: 2213-2219. Yang Z, Nassar R, Dolber PC, Fraser MO: Voltage-dependent potassium currents of urethral afferent neurons in diabetes mellitus. Brain Res. 2008;1217: 132-138. Yokoyama T, Nozaki K, Fujita O, et al: Role of C afferent fibers and monitoring of intravesical resiniferatoxin therapy for patients with idiopathic detrusor overactivity. J Urol 2004; 172: 596-600. Yono M, Latifpour J, Yoshida M, Ueda S: Age-related alterations in the biochemical and functional properties of the bladder in type 2 diabetic GK rats. J Recept Signal Transduct Res. 2005; 25: 147-57. Yoon KH, Lee JH, Kim JW, Cho JH, Choi YH, Ko SH, Zimmet P, Son HY: Epidemic obesity and type 2 diabetes in Asia. Lancet. 2006; 368: 1681-1688. Yoshida M, Miyamae K, Iwashita H, Otani M and Inadome A: Management of detrusor dysfunction in the elderly: changes in acetylcholine and adenosine triphosphate release during aging. Urology 2004; 63: 17-23. Yoshimura N, Chancellor MB, Andersson KE, Christ GJ: Recent advances in understanding the biology of diabetes-associated bladder complications and novel therapy. BJU Int. 2005; 95: 733-738. Yu HJ, Liu CY, Lee KL, Lee WC, Chen TH: Overactive bladder syndrome among community-dwelling adults in Taiwan: prevalence, correlates, perception, and treatment seeking. Urol Int. 2006; 77: 327-333. Zeng M, Zhang H, Lowell C and He P: Tumor necrosis factor alpha-induced leukocyte adhesion and microvessel permeability. Am J Physiol Heart Circ Physiol 2002; 283: H2420-2430. Zenser TV, Thomasson DL, Davis BB: Characteristics of bradykinin and TPA increases in the PGE2 levels of human urothelial cells. Carcinogenesis. 1988; 9: 1173-1177. | |
dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/43402 | - |
dc.description.abstract | 背景
近數十年來,由於全世界的經濟進展,使得人類營養過剩與肥胖的問題日趨嚴重。胰島素抗性引發之代謝性疾病如代謝症或第二型糖尿病之盛行率在亞洲與婦女人口也大幅提高。這些代謝性疾病在目前已知的研究裡,都能引起膀胱失能。糖尿病膀胱失能是第二型糖尿病患者重要的合併症之ㄧ,在門診或社區型患者中有相當高的盛行率。第二型糖尿病膀胱失能這個問題相對於其他糖尿病病變而言,常常被忽視。主要是由於病徵不明顯且醫師與患者皆缺乏警覺性。同時,學界對於此合併症的致病機轉、疾病進程與治療方針,皆未有效掌握。 而代謝症所繼發之膀胱失能,則是一個新興的題目。在一些流行病學調查中,學者們漸漸發現,代謝症能造成多方之影響。在中等程度的胰島素抗性產生後,第二型糖尿病、多囊性卵巢症候群、心血管疾病、與高血壓等也隨之而來。當胰島素抗性產生而未達糖尿病之時,代謝症似乎已能引起種種病徵,其中也包括了下泌尿道症狀的出現與增加前列腺肥大的風險。學者報告代謝症症患者之夜尿、尿流速減弱與排空不良的風險增加。這些問題的產生則歸咎於代謝症候群的干擾。 在代謝症的研究裡,胰島素抗性的出現被認為是重要的病徵,而第二型糖尿病正是由胰島素抗性所引起,因此代謝症也被認為是一種糖尿病前期的表現。在本論文的研究裡,我們主要針對第二型糖尿病婦女患者進行尿路動力學檢查與膀胱內電流感覺閥值測試,來了解糖尿病膀胱失能的致病機轉。同時,以高果糖飼料餵養大白母鼠建立代謝症動物模式,進而研究代謝症膀胱病變。藉由此兩種研究模式來明瞭代謝性疾病所繼發之膀胱病變。 目標、材料與方法 臨床研究: 女性糖尿病患者之排尿障礙與膀胱內感覺閥值測定的關聯性研究 本計劃的目標為研究無干擾因子下的糖尿病膀胱病變患者,糖尿病膀胱病變的發生與周邊神經病變的相關性。我們測量糖尿病患者膀胱內電流感覺閥值 (Current perception thresholds) 測定膀胱內感覺神經Aδ與C纖維的反應,配合傳統尿路動力學檢查的診斷來了解膀胱內感覺缺失與糖尿病膀胱病變的關聯性。在通過人體試驗委員會審查之後,從2005年7月到2007年4月,我們由門診中召集86名女性糖尿病患者進行膀胱尿路動力學檢查與膀胱內電刺激測試。在收集病例的過程中,若患者具有中風或曾經接受過骨盆腔手術等病史、理學檢查發現膀胱脫垂、尿液檢查顯示正處於尿路感染的病人皆直接排除在外。我們以尿路動力學檢查之診斷分類糖尿病患者之膀胱功能,並比較其膀胱內電流感覺測試的結果。 基礎研究:高果糖飼料長期餵養大白母鼠誘發代謝症膀胱病變之動物模式 以果糖飼養大白鼠,使老鼠產生肥胖、高血壓、及高血脂,是一廣為採用的代謝症動物的模式。我們以高果糖飼料餵養大白鼠分別餵養3、6個月以進行膀胱病變研究。在實驗中,我們以代謝箱、膀胱壓、逼尿肌電場刺激與藥物濃度收縮力實驗,來了解代謝症果糖鼠之膀胱生理功能。同時以顯微鏡、電子顯微鏡研究膀胱形態學。最後以西方墨點法研究膀胱內神經受體P2X1-purinergic receptor、 M2-muscarinic receptor、M3-muscarinic receptor蛋白質濃度的改變。 結果 第一部分:臨床研究 在這86名女性糖尿病患者中。其中有33(38.4%)名患者顯示正常之逼尿肌功能,30(34.9%)名患者出現逼尿肌無力,12(14.0%)名患者出現逼尿肌過動,11(12.8%)名患者出現膀胱出口阻塞。在本實驗中,糖尿病女性之膀胱出口阻塞經診斷後多為骨盆底肌肉無法放鬆,同時此類病人可能對於逼尿肌功能的評估造成干擾的效果,因此排除於膀胱內電流感覺閥值的統計。膀胱內電流感覺閥值的統計顯示,相對於正常之逼尿肌功能與逼尿肌過動的糖尿病患者,逼尿肌無力的患者有較高的膀胱內電流感覺閥值。若將無力組與逼尿肌正常組合併進行多變量分析,我們發現膀胱內感覺閥值的增加與膀胱排空效率下降呈現有意義的關連。 第二部份: 基礎研究 研究顯示,以高果糖飼料餵養大白母鼠達三個月以後皆可以順利誘發代謝症產生,其中有66.7%的果糖鼠會產生不正常的膀胱波形。以逼尿肌進行電場刺激與藥物濃度收縮力實驗後發現,3個月組只有以高濃度的氯化鉀刺激才能顯示果糖鼠逼尿肌收縮力下降的差別。而6個月組的研究顯示,在電場頻率、氯化鉀carbachol刺激下,果糖鼠逼尿肌收縮力明顯下降。而以高濃度的ATP刺激時,果糖鼠逼尿肌收縮力呈現有意義的增加。形態學檢查則顯示有果糖鼠逼尿肌有白血球浸潤的發炎前期現象,電子顯微鏡下則發現果糖鼠逼尿肌的粒線體腫脹與橡樹葉化(Oak leaf like)的特徵。西方墨點法顯示果糖鼠膀胱內神經受體M2-muscarinic receptor、M3-muscarinic receptor蛋白質濃度增加。而P2X1-purinergic receptor蛋白質在3個月組沒有明顯變化,而6個月組的果糖鼠膀胱內的P2X1-purinergic receptor蛋白質有濃染的情形。 結論 胰島素抗性相關的代謝性疾病能以不同的形式引發膀胱失能,在門診病人的研究中,我們發現逼尿肌無力的糖尿病患者具有較高的膀胱內電流感覺閥值,這說明感覺缺失對於逼尿肌無力型糖尿病膀胱病變具有高度的意義。我們的研究對於糖尿病膀胱內感覺缺損直接造成膀胱收縮無力提供一個電生理學的證據。而在高果糖餵養的代謝症動物模式裡,我們的研究顯示有一部分的代謝症果糖鼠會發生膀胱形態學、生理功能的改變。這種改變與發炎前期、逼尿肌病變與膀胱內神經末梢受體變化有關。 | zh_TW |
dc.description.abstract | Background
Insulin resistance related metabolic disease have become an important worldwide public health problem because the prevalence has risen steadily during recent decades, particularly in the Asian and female populations. Rapid economic development and urbanization have increased the prevalence of metabolic syndrome and type 2 diabetes in Asia. Both metabolic syndrome and type 2 diabetes are known to be risk factors for the development of bladder dysfunction. Metabolic diseases are likely to result in major economic burdens for countries in Asia, the most populous area in the world. Diabetic bladder dysfunction is one of the most frequent complications of diabetes mellitus. Over 50 % of patients with diabetes exhibit diabetic bladder dysfunction. Although the complications of diabetes mellitus have been well studied, the development and severity of lower urinary tract disorders in patients with diabetes mellitus are still poorly understood. The bladder dysfunction secondary to metabolic syndrome is the other interesting issue. The patients with metabolic syndrome also have a higher risk of lower urinary tract symptoms. To study the bladder dysfunction secondary to metabolic syndrome plays an important role in the prevention and early treatment of diabetic complications. Insulin resistance is the core metabolic perturbation of the metabolic syndrome and can result in type 2 diabetes. Moderate degrees of insulin resistance are closely linked to a range of common disease, such as polycystic ovary syndrome, obesity, hypertension and benign prostatic hyperplasia. Currently, metabolic syndrome is considered as a pre-diabetic status. In this dissertation, we present our observations on the bladder dysfunction secondary to metabolic diseases related to insulin resistance. In human study, the urodynamic studies along with the intravesical CPT test were used to evaluate the lower urinary tract function in type 2 diabetic women. We also established an animal model of fructose-fed rats to study the bladder dysfunction secondary to metabolic syndrome. Aims, materials and methods Clinic study: The relationship between urodynamic findings and intravesical current perception thresholds testing among diabetic bladder women. Eighty-six consecutive type 2 diabetic women followed-up at a diabetes clinic with minimal confounders of voiding dysfunction were prospectively enrolled and subjected to urodynamic studies. The sensory response of Aδ- and C-fibers of the bladder was measured by intravesical current perception threshold (CPT) testing at frequencies of 250 and 5 Hz, respectively. Basic study: Bladder dysfunction in rats with metabolic syndrome induced by long-term fructose feeding. Female Wistar rats were fed with fructose-enriched (60%) or control diet for three and six months. In vitro contractile responses to electric field stimulation, KCl, carbachol, adenosine triphosphate and in vivo cystometry were used to evaluate bladder function. Tissue staining and electron microscopy were also performed to evaluate the structural changes in rats subjected to metabolic syndrome. The western blotting was used to evaluate the protein amount of M2-muscarinic、M3-muscarinic and P2X1-purinergic receptors in the bladder. Biochemical and physiological data were compared between fructose-fed rats and age-matched controls. Results: Part I: Clinic study Of these 86 women, 30 (34.9%) were classified as detrusor underactivity, 12 (14.0%) presented signs of detrusor overactivity, 11 (12.8%) were referred as bladder outlet obstruction, and 33 (38.4%) showed a normal detrusor function in urodynamics. The normal detrusor function group was the reference group. The detrusor underactivity group showed impaired emptying function and decreased sensation both in cystometry and intravesical CPT testing. The detrusor overactivity group showed impaired storage and emptying function, but had no significant changes in intravesical CPT values. When the normal detrusor function group and detrusor underactivity group were pooled to perform multivariate analysis, an increase in CPT values was associated with a decrease in bladder voiding efficiency in both 5 Hz and 250 Hz CPT testing. Part II: Basic study All rats fed with fructose-enriched diet for three months developed insulin resistance, hyperinsulinemia, hypertriglycemia, and hypertension. These fructose-fed rats showed a decreased contractile response to high concentrations of KCl, but not to other parameters tested when compared to controls. Eight of the twelve (66.7%) rats showed abnormal cystometry, mainly by increased phasic contractions. In the six-months fructose-fed rats, contractile responses to electric field stimulation, KCl and carbachol were decreased significantly. However, responsiveness to high concentrations of adenosine triphosphate was significantly increased. Morphologic studies on fructose-fed rats showed swollen mitochondria of bladder smooth muscle, increased leukocyte infiltration between interstitial tissue, and neutrophil adhesion around the endothelium of vessels. An up-regulation of M2-muscarinic and M3-muscarinic receptors was observed in 3-month and 6 month fructose-fed rats. The increase amount of P2X1-purinergic receptors in the bladder was also noted in 6 month fructose-fed rats. Conclusion: Bladder dysfunction secondary to metabolic diseases related to insulin resistance has prominent morbidity and affected deeply. Our data of human study provided the electrophysiological evidence that indicates an association between impaired Aδ- as well as C-fiber bladder afferent pathways and poor emptying function in diabetic women with detrusor underactivity. Our animal model showed that a significant proportion of fructose-fed rats develop time-related alterations in the biochemical, morphological and functional properties of the bladder. The proinflammation and myopathy of the bladder induced by metabolic perturbations play important roles in causing bladder dysfunction. | en |
dc.description.provenance | Made available in DSpace on 2021-06-15T01:54:33Z (GMT). No. of bitstreams: 1 ntu-98-D93421101-1.pdf: 2181105 bytes, checksum: f15208be00ca276cf3b080ad08472eb8 (MD5) Previous issue date: 2009 | en |
dc.description.tableofcontents | 中文摘要 P.1
英文摘要 P.5 博士論文本文 第一章、緒論 P.11 第一節、前言 P.11 第二節、糖尿病對於下泌尿道系統的影響 P.15 第三節、代謝症對於下泌尿道功能的影響 P.24 第四節、膀胱傳入神經與傳出神經的訊息傳遞機轉 P.27 第五節、膀胱內的電流閥值測試 P.30 第六節、研究目的 P.31 第七節、第二型糖尿病膀胱病變患者致病機轉之臨床研究假說 P.33 第八節、高果糖飼料誘發大白鼠產生代謝症膀胱病變之基礎研究假說 P.35 第二章、研究方法與材料料 P.36 第一節、女性糖尿病患者之早期糖尿病排尿障礙與膀胱內電流感覺閥值測定的關聯性研究P.36 第二節、以高果糖飼料長期餵養大白母鼠誘發代謝症與膀胱病變 P.39 第三章、結果 P.46 第一部份 第二型糖尿病婦女早期膀胱病變之研究P.46 第一節、 第二型糖尿病婦女研究樣本之描述性統計與尿路動態檢查分組比較 P.46 第二節、 膀胱內電流感覺測試之比較與尿動力學參數之相關性P.48 第二部份 以高果糖飼料誘發代謝症大白鼠之膀胱失能 P.50 第三節、高果糖飼料誘發代謝症大白鼠之臨床數值表現 P.50 第四節、具有胰島素抗性的果糖代謝症大白母鼠之膀胱功能評估結果 P.51 第五節、果糖代謝鼠膀胱之結構異常與逼尿肌上之運動神經末端受體異常 P.53 第四章、討論 P.54 第一節、因胰島素抗性引起的第二型糖尿病患者的尿路動態檢查特色 P.54 第二節、 因胰島素抗性引起的第二型糖尿病患者的膀胱失能致病因子探討 P.57 第三節、 高果糖飼料誘發大白鼠產生胰島素抗性與代謝異常對膀胱功能的影響 P.62 第四節、代謝症裡胰島素抗性、肥胖、發炎、與膀胱失能的相關性P.66 第五章、展望 P. 69 第一節、胰島素抗性引致之第二型糖尿病膀胱失能的治療策略 P.69 第二節、胰島素抗性引致之代謝症膀胱失能的治療策略 P.73 第三節、代謝症、下泌尿道症狀與勃起障礙的關連性與探討 P.76 英文簡述(English Summary) P.79 參考文獻 P. 89 圖表 P.101 附錄: 博士修業期間所發表之相關論文清冊 P. 115 | |
dc.language.iso | zh-TW | |
dc.title | 與胰島素抗性相關之代謝性疾病繼發之膀胱失能 | zh_TW |
dc.title | Bladder dysfunction secondary to metabolic diseases related to insulin resistance | en |
dc.type | Thesis | |
dc.date.schoolyear | 97-2 | |
dc.description.degree | 博士 | |
dc.contributor.advisor-orcid | ,鄭劍廷(ctchien@ntu.edu.tw) | |
dc.contributor.oralexamcommittee | 陳世乾(Hsing-Hsieh Cheng),唐一清(Yat-Ching Tong),莊燿吉(Yao-Chi Chuang),楊偉勛(Wei-Shiung Yang) | |
dc.subject.keyword | 代謝症,糖尿病,膀胱,排尿障礙,大鼠, | zh_TW |
dc.subject.keyword | metabolic syndrome,diabetes,bladder,urination disorders,rat, | en |
dc.relation.page | 115 | |
dc.rights.note | 有償授權 | |
dc.date.accepted | 2009-06-30 | |
dc.contributor.author-college | 醫學院 | zh_TW |
dc.contributor.author-dept | 臨床醫學研究所 | zh_TW |
顯示於系所單位: | 臨床醫學研究所 |
文件中的檔案:
檔案 | 大小 | 格式 | |
---|---|---|---|
ntu-98-1.pdf 目前未授權公開取用 | 2.13 MB | Adobe PDF |
系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。